What is the "Classic GH stack (with CJC-1295)" protocol for Ipamorelin?

200-300 mcg + 100 mcg CJC · 2-3× daily · 8-12 weeks

What is the "Pre-bed monotherapy" protocol for Ipamorelin?

300 mcg · 1× pre-bed · 12 weeks

Dosing

Ipamorelin - dosing protocol

Standard Ipamorelin dose is 200-300 mcg under the skin (s.c. injection) 2-3× daily (pre-breakfast, pre-workout, pre-bed). Frequently stacked with CJC-1295 for a dual growth-hormone pulse. Cycles run 8-12 weeks with a 4-week off period.

Route

Subcutaneous (s.c.)

Dose

200-300 mcg / administration

Half-life

~2 hours

Storage

-20°C lyophilized; reconstituted — 21 days at 2-8°C

Dosing regimens

Standard regimens from the literature. The choice depends on what you're trying to achieve.

Protocol

Classic GH stack (with CJC-1295)

Dose: 200-300 mcg + 100 mcg CJC
Frequency: 2-3× daily
Duration: 8-12 weeks

Protocol

Pre-bed monotherapy

Dose: 300 mcg
Frequency: 1× pre-bed
Duration: 12 weeks

Side effects

Ipamorelin is known for a clean profile — selective GHRP without cortisol, prolactin, or appetite spikes (unlike GHRP-6). Most common are mild hunger at higher doses and transient water retention from GH signaling.

See full side-effect list

Encyclopedia

Full scientific profile for Ipamorelin

Calculator

What does this protocol cost per day?

Last reviewed: 6 May 2026by PeptidLabs Editorial

Dosing

Ipamorelin - dosing protocol

Route

Subcutaneous (s.c.)

Dose

200-300 mcg / administration

Half-life

~2 hours

Storage

-20°C lyophilized; reconstituted — 21 days at 2-8°C

Dosing regimens

Standard regimens from the literature. The choice depends on what you're trying to achieve.

Protocol

Classic GH stack (with CJC-1295)

Dose: 200-300 mcg + 100 mcg CJC
Frequency: 2-3× daily
Duration: 8-12 weeks

Protocol

Pre-bed monotherapy

Dose: 300 mcg
Frequency: 1× pre-bed
Duration: 12 weeks

Side effects

See full side-effect list

Encyclopedia

Full scientific profile for Ipamorelin

Calculator

What does this protocol cost per day?

Last reviewed: 6 May 2026by PeptidLabs Editorial